Subscribe to RSS
DOI: 10.1055/s-2006-957081
Petasiphenone, a Phenol Isolated from Cimicifuga Racemosa, in vitro Inhibits Proliferation of the Human Prostate Cancer Cell Line LNCaP
Publication History
Received: August 28, 2006
Accepted: December 5, 2006
Publication Date:
13 February 2007 (online)
Abstract
Extracts of Cimicifuga racemosa (L.) Nutt. (syn.: Actaea racemosa L.) (CR) inhibit the proliferation of the human prostate cancer cell line LNCaP. Recently, the phenylpropanoid ester 3,4-dihydroxyphenacyl caffeate (petasiphenone, 1) was isolated from CR. This substance is a structural homologue to petasiphenol ([3-(3,4-dihydroxyphenyl)-2-oxopropyl caffeate]), a compound produced by Petasites japonicus Sieb. & Zucc. which inhibits the growth of various human leukemia cell lines. Because of the structural similarity, we examined whether 1 affects the proliferation of LNCaP cells and the secretion of prostate-specific antigen (PSA). Under basal conditions as well as under co-incubation with 10 nM estradiol [E2 or 1 nM dihydrotestosterone (DHT)], 1 dose-dependently inhibited proliferation of LNCaP cells while PSA release per cell was not altered. We report for the first time that a defined compound isolated from CR inhibits the growth of the human prostate cancer cells LNCaP.
- Supporting Information for this article is available online at
- Supporting Information .
References
- 1 Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. Anticancer Res. 2005; 25 139-47
- 2 Jarry H, Thelen P, Christoffel V, Spengler B, Wuttke W. Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP. Phytomedicine. 2005; 12 178-82
- 3 Stromeier S, Petereit F, Nahrstedt A. Phenolic esters from the rhizomes of Cimicifuga racemosa do not cause proliferation effects in MCF-7 cells. Planta Med. 2005; 71 495-500
- 4 Mizushina Y, Hirota M, Murakami C, Ishidoh T, Kamisuki S, Shimazaki N. et al . Some anti-chronic inflammatory compounds are DNA polymerase lambda-specific inhibitors. Biochem Pharmacol. 2003; 66 1935-44
- 5 Matsubara K, Mori M, Mizushina Y. Petasiphenol which inhibits DNA polymerase lambda activity is an inhibitor of in vitro angiogenesis. Oncol Rep. 2004; 11 447-51
- 6 Mizushina Y, Kamisuki S, Kasai N, Ishidoh T, Shimazaki N, Takemura M. et al . Petasiphenol: a DNA polymerase lambda inhibitor. Biochemistry. 2002; 41 14 463-71
- 7 Culig Z, Klocker H, Bartsch G, Hobisch A. Androgen receptors in prostate cancer. Endocr Relat Cancer. 2002; 9 155-70
- 8 Arnold J T, Le H, McFann K K, Blackman M R. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab. 2005; 288 E573-84
- 9 Jana N R, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C, Sone H. Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells. Biochem Biophys Res Commun. 1999; 256 462-8
Prof. Dr. Hubertus Jarry
Division of Clinical and Experimental Endocrinology
Department of Obstetrics and Gynaecology
University of Göttingen
Robert Koch-Strasse 40
37075 Göttingen
Germany
Phone: +49-551-396-522
Fax: +49-551-396-518
Email: hubjarry@med.uni-goettingen.de
- www.thieme-connect.de/ejournals/toc/plantamedica